J M Kilpatrick
Overview
Explore the profile of J M Kilpatrick including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
230
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
WHITTINGHAM H, Kilpatrick J, Griffiths E
Br Med J
. 2010 Aug;
1(3677):1101-8.
PMID: 20776241
No abstract available.
2.
Kilpatrick J, MacPherson W, Barton J, Jones J
Appl Opt
. 2008 Mar;
39(9):1382-8.
PMID: 18338022
The influence of reflector losses attracts little discussion in standard treatments of the Fabry-Perot interferometer yet may be an important factor contributing to errors in phase-stepped demodulation of fiber optic...
3.
Kilpatrick J, Moore A, Barton J, Jones J, Reeves M, Buckberry C
Opt Lett
. 2007 Dec;
25(15):1068-70.
PMID: 18064273
We describe a high-speed digital speckle pattern interferometer incorporating a line-scan camera and a waveguide phase modulator for the measurement of complex deformation (vibration phase and amplitude) at audio acoustic...
4.
Zhang J, Krishnan R, Arnold C, Mattsson E, Kilpatrick J, Bantia S, et al.
Med Chem
. 2006 Nov;
2(6):545-53.
PMID: 17105435
Uncontrolled kallikrein activation is involved in diseases such as hereditary angioedema, bacterial septic shock and procedures such as cardiopulmonary bypass. Here we report a series of small molecule compounds that...
5.
Bantia S, Miller P, Parker C, Ananth S, HORN L, Kilpatrick J, et al.
Int Immunopharmacol
. 2001 Jun;
1(6):1199-210.
PMID: 11407314
Patients with purine nucleoside phosphorylase (PNP) deficiency present a selective T-cell immunodeficiency. Inhibitors of PNP are, therefore, of interest as potential T-cell selective immunosuppressive agents. BCX-1777 is a potent inhibitor...
6.
Szalai A, Digerness S, Agrawal A, Kearney J, Bucy R, Niwas S, et al.
J Immunol
. 1999 Dec;
164(1):463-8.
PMID: 10605043
We induced reverse passive Arthus (RPA) reactions in the skin of rodents and found that the contribution of complement to immune complex-mediated inflammation is species specific. Complement was found to...
7.
Cole L, Kilpatrick J, Chu N, Babu Y
Acta Crystallogr D Biol Crystallogr
. 1998 Oct;
54(Pt 5):711-7.
PMID: 9757085
Factor D (D) is a serine protease essential in the activation of the alternative complement pathway. Only a few of the common serine protease inhibitors inhibit D, binding covalently to...
8.
Jing H, Babu Y, Moore D, Kilpatrick J, Liu X, Volanakis J, et al.
J Mol Biol
. 1998 Oct;
282(5):1061-81.
PMID: 9753554
Factor D is a serine protease essential for the activation of the alternative pathway of complement. The structures of native factor D and a complex formed with isatoic anhydride inhibitor...
9.
Cole L, Chu N, Kilpatrick J, Volanakis J, Narayana S, Babu Y
Acta Crystallogr D Biol Crystallogr
. 1997 Mar;
53(Pt 2):143-50.
PMID: 15299948
Factor D (D) is a serine protease, crucial for the activation of the alternative complement pathway. Only a limited number of general serine protease inhibitors are known to inhibit D,...
10.
Narayana S, Carson M, El-Kabbani O, Kilpatrick J, Moore D, Chen X, et al.
J Mol Biol
. 1994 Jan;
235(2):695-708.
PMID: 8289289
Factor D, an essential enzyme for the activation of the alternative pathway of the complement system, belongs to the serine protease superfamily. The crystal structure of the enzyme was solved...